Health
OXGENE launches a scalable, plasmid-free manufacturing system for AAV – News-Medical.net
OXGENE™, a biotechnology company designing and developing scalable gene therapy technologies, has today announced the launch of its scalable, plasmid-free manufacturing system for AAV.
OXGENE™, a biotechnology company designing and developing scalable gene therapy technologies, has today announced the launch of its scalable, plasmid-free manufacturing system for AAV. OXGENE’s new TESSA™ technology addresses industry-wide challenges associated with robust and reproducible AAV manufacture at scale. These include high cost of goods, and low packaging efficiency. TESSA aims to deliver a paradigm shift in scalable AAV manufacture.
Adeno-associated virus, or AAV, is a popular choic…
-
General24 hours agoSector warns Coalition’s plan to limit overseas students ‘straight out of Trump’s playbook’
-
Noosa News22 hours agoBrisbane’s covert cameras catching more than just litterbugs
-
Noosa News24 hours agoMeasles alert issued across popular south-east attractions
-
General16 hours agoPope Francis makes surprise first appearance after hospital stay